Skip to Main Content
Medicines and Healthcare products Regulatory Agency logo
  • Healthcare professionals
  • Patients and public
  • Pharmaceutical industry
  • Devices industry


  • Home
  • Contact us
  • Stay connected
  • FAQs
  • Glossary
  • Sitemap
  • Help
  • A to Z
Loading MHRA search...
  • About us
  • How we regulate
  • Safety information
  • Committees
  • Conferences and education
  • Publications and consultations
  • Media Centre

Home   Related links

Related link item

Sibutramine: Suspension of marketing authorisation as risks outweigh benefits
  • © Crown Copyright 2012
  • Terms & conditions
  • Freedom of information
  • Accessibility
  • Careers @ MHRA
  • Sitemap
  • Contact us
Investors in People

Head office: 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ
General enquiries: info@mhra.gsi.gov.uk
To contact us about this website, use our feedback form